Premarket Mover: Cardiff Oncology Inc (CRDF) Up 7.22%

Cardiff Oncology Inc (CRDF) is up Thursday morning, with the stock gaining 7.22% in pre-market trading to 5.79. CRDF's short-term technical score of 98 indicates that the stock has traded more bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 101 out of 146 industries, the stock ranks higher than 99% of stocks. Cardiff Oncology Inc has risen 196.70% over the past month, closing at $1.75 on February 15. During this period of time, the stock fell as low as $1.67 and as high as $4.59. CRDF has an average analyst recommendation of Strong Buy. The company has an average price target of $10.50.

CRDF has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on CRDF!

See Full CRDF Report

Cardiff Oncology Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 72 by this metric, CRDF ranks better than 72% of stocks.

Important Dates for Investors in CRDF:

-Cardiff Oncology Inc is set to release earnings on 2024-05-02. Over the last 12 months, the company has reported EPS of $-0.92. -We do not have a set dividend date for Cardiff Oncology Inc at this time. Click Here To Get The Full Report on Cardiff Oncology Inc (CRDF)